Finance

Lists
Why is SSKN up 100,00%?
Dive Deeper
SSKN:OTCMKTS
STRATA Skin Sciences Inc
0,00020 $
+100,00%
(+0,00010) 1D
9 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SSKN...
Open
0,00 $
High
0,00 $
Low
0,00 $
Mkt. cap
588,80
Avg. vol.
2,36 мың
Volume
182,00
52-wk high
2,65 $
52-wk low
0,00 $
EPS
-1,35 $
Beta
0,06
Shares outstanding
5,89 млн
No. of employees
114
Open
0,00 $
High
0,00 $
Low
0,00 $
Mkt. cap
588,80
Avg. vol.
2,36 мың
Volume
182,00
52-wk high
2,65 $
52-wk low
0,00 $
EPS
-1,35 $
Beta
0,06
Shares outstanding
5,89 млн
No. of employees
114
News stories
From web sources and news partners
Profile
Strata Skin Sciences is an American medical device company focused on the design, development and commercialization of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations. The company's flagship product, XTRAC, is a medical device that allows for a trained dermatologist to treat skin conditions like Vitiligo and Psoriasis with monochromatic UV Light. Following completion of a successful conformity assessment procedure, Strata Skin Sciences has also been granted CE Mark approval for sale of MelaFind in the European Union. In July 2015, the company acquired PhotoMedex Inc. and is planning to relocate its headquarters from Irvington, New York to Horsham, Pennsylvania in Montgomery County. Wikipedia
About STRATA Skin Sciences Inc
CEO-
Employees114
Founded1989 ж. 01 қаң.
HeadquartersHorsham Township, Пенсильвания, Америка Құрама Штаттары
SectorMedical device
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. нау.
2025 ж. мау.
2025 ж. қыр.
2025 ж. жел.
Revenue
6,81 млн
7,66 млн
6,93 млн
9,29 млн
Cost of goods sold
3,16 млн
3,36 млн
2,74 млн
3,68 млн
Cost of revenue
3,16 млн
3,36 млн
2,74 млн
3,68 млн
Research and development expenses
96,00 мың
86,00 мың
172,00 м.
67,00 мың
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,57 млн
6,44 млн
5,87 млн
5,51 млн
Operating expense
5,66 млн
6,53 млн
6,04 млн
5,58 млн
Total operating expenses
8,83 млн
9,89 млн
8,79 млн
9,26 млн
Operating income
-2,02 млн
-2,22 млн
-1,86 млн
37,00 мың
Other non operating income
-
-
-
-
EBT including unusual items
-2,43 млн
-2,49 млн
-1,62 млн
70,00 мың
EBT excluding unusual items
-2,43 млн
-2,49 млн
-2,31 млн
-381,00 м.
Income tax expense
-
-
-
12,00 мың
Effective tax rate
-
-
-
17,14%
Other operating expenses
-
-
-
-
Net income
-2,43 млн
-2,49 млн
-1,62 млн
58,00 мың
Net profit margin
-35,70%
-32,48%
-23,41%
0,62%
Earnings per share
-0,58
-0,60
-0,36
-
Interest and investment income
69,00 мың
226,00 м.
49,00 мың
66,00 мың
Interest expense
-486,00 м.
-491,00 м.
-498,00 м.
-484,00 м.
Net interest expenses
-417,00 м.
-265,00 м.
-449,00 м.
-418,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-795,00 м.
-1,01 млн
-993,00 м.
858,00 м.
Gain or loss from assets sale
34,00 мың
29,00 мың
20,00 мың
9,00 мың
AI content may include mistakes. Learn more
Google қолданбалары